Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.04M Sell
19,430
-1,301
-6% -$445K 0.08% 263
2026
Q1
$7.29M Buy
20,731
+5,313
+34% +$1.89M 0.09% 223
2025
Q4
$5.05M Buy
15,418
+1,796
+13% +$570K 0.07% 263
2025
Q3
$3.84M Sell
13,622
-207
-1% -$60K 0.06% 315
2025
Q2
$3.86M Buy
13,829
+2,771
+25% +$785K 0.09% 195
2025
Q1
$3.45M Buy
11,058
+492
+5% +$145K 0.1% 180
2024
Q4
$2.75M Buy
10,566
+2,018
+24% +$599K 0.1% 170
2024
Q3
$2.75M Buy
8,548
+2,411
+39% +$789K 0.11% 148
2024
Q2
$1.92M Buy
6,137
+3,159
+106% +$928K 0.09% 161
2024
Q1
$847K Buy
2,978
+5
+0.2% +$1.46K 0.05% 207
2023
Q4
$856K Buy
2,973
+20
+0.7% +$5.45K 0.06% 188
2023
Q3
$794K Sell
2,953
-3,384
-53% -$845K 0.06% 186
2023
Q2
$1.41M Buy
6,337
+955
+18% +$222K 0.1% 114
2023
Q1
$1.3M Buy
5,382
+246
+5% +$60.4K 0.11% 92
2022
Q4
$1.35M Buy
5,136
+172
+3% +$46.1K 0.13% 84
2022
Q3
$1.12M Buy
4,964
+1,122
+29% +$272K 0.11% 93
2022
Q2
$935K Buy
3,842
+235
+7% +$57.6K 0.09% 103
2022
Q1
$872K Buy
3,607
+453
+14% +$104K 0.07% 130
2021
Q4
$710K Buy
3,154
+918
+41% +$194K 0.05% 141
2021
Q3
$475K Buy
2,236
+1,086
+94% +$250K 0.04% 146
2021
Q2
$280K Buy
+1,150
New +$283K 0.03% 139

Other funds holding AMGN

Summit Financial's AMGN Position: Q2 2026 in Review

Summit Financial reduced its Amgen (AMGN) stake by 6.3% in Q2 2026, selling an estimated $445K and leaving 19,430 shares worth $7.04M. The position accounts for 0.08% of the portfolio, ranked #263.

Summit Financial first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.29M in Q1 2026. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Summit Financial held 19,430 shares of Amgen worth $7.04M as of Q2 2026.
  • Summit Financial sold 1,301 Amgen shares in Q2 2026, an estimated $445K.
  • Amgen made up 0.08% of Summit Financial's portfolio in Q2 2026, its #263 holding.
  • Summit Financial first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
  • Summit Financial's Amgen position peaked at $7.29M in Q1 2026.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.